Literature DB >> 23907344

Stress echocardiography in clinical practice: a United Kingdom National Health Service Survey on behalf of the British Society of Echocardiography.

Sanjeev Bhattacharyya1, Omar Chehab, Rajdeep Khattar, Guy Lloyd, Roxy Senior.   

Abstract

AIMS: Stress echocardiography (SE) is one of the leading modalities for the assessment of coronary artery disease and dynamic valvular heart disease. A wide range of different techniques have been established. There are no data which identify how current techniques have been integrated into clinical practice. METHODS AND
RESULTS: An electronic questionnaire was devised to identify SE practice in five core areas: service demographics, indications, methods, reporting, and adverse events. The questionnaire was sent to 198 National Health Service hospitals. Eighty-five (71%) out of the 120 departments who perform SE responded. Each unit performed a median of 400 SE (inter-quartile range 175-600). Thirty-two (37.6%) operators performed <100 SE per year. Exercise, dobutamine, dipyridamole, adenosine, and pacing SE were available in 57 (67.1%), 85 (100%), 6 (7.1%), 11 (12.9%), and 34 (40%) units, respectively. Eighty-one (95.3%) units performed SE for the evaluation of low-flow, low-gradient aortic stenosis. Thirty-four (40%) and 32 (37.6%) performed SE for the evaluation of asymptomatic severe aortic stenosis and symptomatic moderate mitral regurgitation, respectively. Eighty-three (97.6%) administered contrast agents during SE. Additional analysis of perfusion and strain was performed in 9 (10.5%) and 13 (15.3%) units, respectively.
CONCLUSION: SE has been incorporated into the majority of UK hospitals. A substantial proportion of operators perform less than the recommended number of procedures per year. The use of exercise SE, vasodilator SE, and SE for the evaluation of VHD are under-utilized. Penetration of new techniques is variable, contrast for left ventricular opacification has been almost universally adopted, while myocardial perfusion and mechanics are used much less.

Entities:  

Keywords:  Coronary artery disease; Stress echocardiography; Valvular heart disease

Mesh:

Substances:

Year:  2013        PMID: 23907344     DOI: 10.1093/ehjci/jet082

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  10 in total

1.  Stress-echocardiography is underused in clinical practice: a nationwide survey in Austria.

Authors:  David Weidenauer; Philipp Bartko; Heidemarie Zach; Manfred Zehetgruber; Hans Domanovits; Senta Graf; Gerald Mundigler
Journal:  Wien Klin Wochenschr       Date:  2015-07-11       Impact factor: 1.704

2.  How to relate diastolic left ventricular dysfunction to the results of stress echocardiography in aortic stenosis?

Authors:  Thomas Bartel; Silvana Müller
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

Review 3.  Echocardiographic assessment of myocardial ischemia.

Authors:  Roman Leischik; Birgit Dworrak; Fabian Sanchis-Gomar; Alejandro Lucia; Thomas Buck; Raimund Erbel
Journal:  Ann Transl Med       Date:  2016-07

4.  Dobutamine Stress Echocardiography Safety in Chagas Disease Patients.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Rogerio Gomes Furtado; Fabio de Paula Turco; Luciano Henrique Melato; Viviane Tiemi Hotta; Colandy Godoy de Oliveira Nunes; Luiz Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2017-01-16       Impact factor: 2.000

5.  Feasibility of physiologist-led stress echocardiography for the assessment of coronary artery disease.

Authors:  Jamal N Khan; Timothy Griffiths; Tamseel Fatima; Leah Michael; Andreea Mihai; Zeeshan Mustafa; Kully Sandhu; Robert Butler; Simon Duckett; Grant Heatlie
Journal:  Echo Res Pract       Date:  2017-06-07

6.  Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography.

Authors:  Richard P Steeds; Richard Wheeler; Sanjeev Bhattacharyya; Joseph Reiken; Petros Nihoyannopoulos; Roxy Senior; Mark J Monaghan; Vishal Sharma
Journal:  Echo Res Pract       Date:  2019-06-01

7.  Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?

Authors:  Victoria Pettemerides; Thomas Turner; Conor Steele; Anita Macnab
Journal:  Echo Res Pract       Date:  2019-06-01

8.  Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK.

Authors:  Elizabeth A Stokes; Brett Doble; Maria Pufulete; Barnaby C Reeves; Chiara Bucciarelli-Ducci; Stephen Dorman; John P Greenwood; Richard A Anderson; Sarah Wordsworth
Journal:  BMJ Open       Date:  2019-07-11       Impact factor: 2.692

9.  Impact of COVID-19 on UK stress echocardiography practice: insights from the EVAREST sites.

Authors:  Cameron Dockerill; William Woodward; Annabelle McCourt; Cristiana Monteiro; Elena Benedetto; Maria Paton; David Oxborough; Shaun Robinson; Keith Pearce; Mark J Monaghan; Daniel X Augustine; Paul Leeson
Journal:  Echo Res Pract       Date:  2021-03

10.  Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study.

Authors:  William Woodward; Cameron Dockerill; Annabelle McCourt; Ross Upton; Jamie O'Driscoll; Katrin Balkhausen; Badrinathan Chandrasekaran; Soroosh Firoozan; Attila Kardos; Kenneth Wong; Gary Woodward; Rizwan Sarwar; Nikant Sabharwal; Elena Benedetto; Nancy Spagou; Rajan Sharma; Daniel Augustine; Apostolos Tsiachristas; Roxy Senior; Paul Leeson; Henry Boardman; Joanna d'Arcy; Abraheem Abraheem; Sanjay Banypersad; Christopher Boos; Sudantha Bulugahapitiya; Jeremy Butts; Duncan Coles; Jacob Easaw; Haytham Hamdan; Shahnaz Jamil-Copley; Gajen Kanaganayagam; Tom Mwambingu; Antonis Pantazis; Alexandros Papachristidis; Ronak Rajani; Muhammad Amer Rasheed; Naveed A Razvi; Sushma Rekhraj; David P Ripley; Kathleen Rose; Michaela Scheuermann-Freestone; Rebecca Schofield; Ayyaz Sultan
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-04-18       Impact factor: 6.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.